Steroid receptor-mediated inhibition of rat prolactin gene expression does not require the receptor DNA-binding domain
- PMID: 3345568
- DOI: 10.1016/0092-8674(88)90406-0
Steroid receptor-mediated inhibition of rat prolactin gene expression does not require the receptor DNA-binding domain
Abstract
Prolactin gene expression is negatively regulated by glucocorticoids, and by estrogens when positive estrogen regulatory elements in the prolactin gene are removed. Mutational analysis of estrogen receptor confirms that inhibition is a function of receptor, and that transcriptional activation and inhibition require distinct, separable structural elements. Inhibition is dependent on a 63 amino acid region (amino acids 251-314) distinct from the DNA-binding and steroid-binding domains. The comparable region of glucocorticoid receptor confers inhibitory actions on a hybrid receptor. Multiple, nonoverlapping sequences in the rat prolactin 5'-flanking genomic region that confer inhibition by both steroid hormones contain related cis-active elements that bind a common, tissue-specific positive transcription factor, called Pit-1. Experimental results indicate that positive and negative transcriptional effects of estrogen receptor are mediated by separate functional domains, and suggest the protein-protein interactions between steroid hormone receptors and other transcription factor(s) mediate inhibition.
Similar articles
-
A single domain of the estrogen receptor confers deoxyribonucleic acid binding and transcriptional activation of the rat prolactin gene.Mol Endocrinol. 1988 Jan;2(1):14-21. doi: 10.1210/mend-2-1-14. Mol Endocrinol. 1988. PMID: 3398840
-
Identification of an estrogen-responsive element from the 5'-flanking region of the rat prolactin gene.Mol Cell Biol. 1987 Dec;7(12):4247-54. doi: 10.1128/mcb.7.12.4247-4254.1987. Mol Cell Biol. 1987. PMID: 3481434 Free PMC article.
-
Regulation of estrogen receptor activation of the prolactin enhancer/promoter by antagonistic activation function-2-interacting proteins.Mol Endocrinol. 1999 Jun;13(6):935-45. doi: 10.1210/mend.13.6.0298. Mol Endocrinol. 1999. PMID: 10379892
-
A family of POU-domain and Pit-1 tissue-specific transcription factors in pituitary and neuroendocrine development.Annu Rev Physiol. 1990;52:773-91. doi: 10.1146/annurev.ph.52.030190.004013. Annu Rev Physiol. 1990. PMID: 2184776 Review.
-
The role of ligand in estrogen receptor regulation of gene expression.Mol Cell Endocrinol. 1991 Jul;78(3):C103-8. doi: 10.1016/0303-7207(91)90114-8. Mol Cell Endocrinol. 1991. PMID: 1778298 Review.
Cited by
-
Selective expression of a normal action of the 1,25-dihydroxyvitamin D3 receptor in human skin fibroblasts with hereditary severe defects in multiple actions of that receptor.J Clin Invest. 1989 Jun;83(6):2093-101. doi: 10.1172/JCI114122. J Clin Invest. 1989. PMID: 2542381 Free PMC article.
-
Marked increases in hepatic NAD(P)H:oxidoreductase gene transcription and mRNA levels correlated with a mouse chromosome 7 deletion.Proc Natl Acad Sci U S A. 1989 Sep;86(17):6699-703. doi: 10.1073/pnas.86.17.6699. Proc Natl Acad Sci U S A. 1989. PMID: 2505256 Free PMC article.
-
Mechanisms of hormone resistance in breast cancer.Breast Cancer Res Treat. 1993;26(2):119-30. doi: 10.1007/BF00689685. Breast Cancer Res Treat. 1993. PMID: 8219249 Review.
-
Cells transformed by a v-Myb-estrogen receptor fusion differentiate into multinucleated giant cells.J Virol. 1997 May;71(5):3760-6. doi: 10.1128/JVI.71.5.3760-3766.1997. J Virol. 1997. PMID: 9094651 Free PMC article.
-
Control of prolactin secretion.Klin Wochenschr. 1990 Dec 4;68(23):1157-67. doi: 10.1007/BF01815271. Klin Wochenschr. 1990. PMID: 2126309 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources